Physicians are aggressively using endoscopy and fine needle aspiration to obtain small bits of tissue from almost any organ in the body if they suspect a tumor--but the amount of tissue is often insufficient for analysis. CompuCyte has created technologies and instruments to analyze small tissue samples.
You may also be interested in...
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
BeiGene's BTK inhibitor for leukemia/lymphoma and Sanofi/Genzyme's enzyme replacement therapy for MPS I among novel drugs newly approved in China.
A new document from the US FDA details acceptable substitutions for COVID-19 testing components that may be difficult to come by. See what the regulatory agency said about it here.